NASDAQ: UPC
Universe Pharmaceuticals Inc Stock

$3.77+0.13 (+3.57%)
Updated Jul 10, 2025
UPC Price
$3.77
Fair Value Price
N/A
Market Cap
$2.12M
52 Week Low
$2.51
52 Week High
$2,465.94
P/E
0x
P/B
0.04x
P/S
0.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.29M
Earnings
$1.09M
Gross Margin
30.4%
Operating Margin
6.74%
Profit Margin
5.6%
Debt to Equity
0.46
Operating Cash Flow
-$5M
Beta
0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

UPC Overview

Universe Pharmaceuticals Incorporated sells traditional Chinese medicines in China. It offers treatments of common chronic health conditions in the elderly and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. Universe Pharmaceuticals was incorporated in 2019 and is based in Ji'An, PRC.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UPC's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical

Industry Rating
B
UPC
Ranked
#34 of 61

Top Ranked Stocks in Industry

View Top Pharmaceutical Stocks

Be the first to know about important UPC news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UPC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UPC was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UPC is good value based on its earnings relative to its share price (0x), compared to the US market average (30.8x)
P/E vs Market Valuation
UPC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more UPC due diligence checks available for Premium users.

Valuation

UPC fair value

Fair Value of UPC stock based on Discounted Cash Flow (DCF)

Price
$3.77
Fair Value
-$3.53
Undervalued by
206.92%
UPC was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

UPC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-28.49x
Market
30.8x
UPC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UPC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

UPC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.04x
Industry
2.24x
UPC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UPC's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
UPC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
UPC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$80.7M
Liabilities
$25.5M
Debt to equity
0.46
UPC's short-term assets ($65.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UPC's short-term assets ($65.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
UPC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

UPC vs Pharmaceutical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UPCC$2.12M+3.57%0.00x0.04x
PRFX$2.06M+1.45%-0.04x1.13x
SHPHF$1.87M+2.04%-0.07x0.57x
AKAN$2.89M+4.44%-0.36x0.68x
RDHL$0.00+1.91%N/A0.00x

Universe Pharmaceuticals Stock FAQ

What is Universe Pharmaceuticals's quote symbol?

(NASDAQ: UPC) Universe Pharmaceuticals trades on the NASDAQ under the ticker symbol UPC. Universe Pharmaceuticals stock quotes can also be displayed as NASDAQ: UPC.

If you're new to stock investing, here's how to buy Universe Pharmaceuticals stock.

What is the 52 week high and low for Universe Pharmaceuticals (NASDAQ: UPC)?

(NASDAQ: UPC) Universe Pharmaceuticals's 52-week high was $2,465.94, and its 52-week low was $2.51. It is currently -99.85% from its 52-week high and 50.2% from its 52-week low.

How much is Universe Pharmaceuticals stock worth today?

(NASDAQ: UPC) Universe Pharmaceuticals currently has 563,338 outstanding shares. With Universe Pharmaceuticals stock trading at $3.77 per share, the total value of Universe Pharmaceuticals stock (market capitalization) is $2.12M.

Universe Pharmaceuticals stock was originally listed at a price of $17,099.96 in Mar 23, 2021. If you had invested in Universe Pharmaceuticals stock at $17,099.96, your return over the last 4 years would have been -99.98%, for an annualized return of -87.81% (not including any dividends or dividend reinvestments).

How much is Universe Pharmaceuticals's stock price per share?

(NASDAQ: UPC) Universe Pharmaceuticals stock price per share is $3.77 today (as of Jul 10, 2025).

What is Universe Pharmaceuticals's Market Cap?

(NASDAQ: UPC) Universe Pharmaceuticals's market cap is $2.12M, as of Jul 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Universe Pharmaceuticals's market cap is calculated by multiplying UPC's current stock price of $3.77 by UPC's total outstanding shares of 563,338.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.